Clinical Trials · NCT06024356
Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for Locally Advanced Mid-low Rectal Cancer
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Beijing Friendship Hospital
- Enrollment
- 47
- Start date
- Sep 2023
- Locations
- 1 site, China
- Primary endpoint
- 3-y DFS